Innovative Research
Supplier of human and animal biological materials and related research services. Offers a catalog of blood- and serum-derived materials (single-donor and pooled), coagulation factor–deficient plasmas, lyophilized formats, immunoassay kits, and sample testing. Provides unit- and lot-level safety and biochemical testing with Certificates of Analysis, documented handling protocols, temperature-controlled logistics, and maintains ISO 9001:2015 certification plus relevant U.S. regulatory registrations for collection facilities.
Industries
Nr. of Employees
small (1-50)
Products
Factor II (FII) deficient human plasma
Citrated pooled human plasma immuno-depleted of prothrombin to defined low residual activity; provided frozen for in vitro research and assay use.
Factor VII (FVII) deficient human plasma
Citrated pooled human plasma immuno-depleted of Factor VII with defined residual activity levels for in vitro assay use.
Factor VIII (FVIII) deficient human plasma
Plasma prepared by chemical depletion to reduce Factor VIII activity while retaining antigen; provided for assay development and validation.
Panel of coagulation factor–deficient plasmas (FIX, FX, FXI, FV, FXII etc.)
A set of coagulation factor–deficient plasmas produced to defined residual activity specifications for use as controls and calibrators in coagulation assays; available in frozen or lyophilized formats product-dependent.
Complement C4 deficient human plasma, lyophilized
Lyophilized human plasma depleted for complement C4, supplied as a stable reconstitutable material for complement pathway research and assay controls.
Serum Amyloid A (SAA) deficient human plasma, lyophilized
Lyophilized human plasma prepared with reduced Serum Amyloid A levels for biomarker and immunoassay applications.
Factor II (FII) deficient human plasma
Citrated pooled human plasma immuno-depleted of prothrombin to defined low residual activity; provided frozen for in vitro research and assay use.
Factor VII (FVII) deficient human plasma
Citrated pooled human plasma immuno-depleted of Factor VII with defined residual activity levels for in vitro assay use.
Factor VIII (FVIII) deficient human plasma
Plasma prepared by chemical depletion to reduce Factor VIII activity while retaining antigen; provided for assay development and validation.
Panel of coagulation factor–deficient plasmas (FIX, FX, FXI, FV, FXII etc.)
A set of coagulation factor–deficient plasmas produced to defined residual activity specifications for use as controls and calibrators in coagulation assays; available in frozen or lyophilized formats product-dependent.
Complement C4 deficient human plasma, lyophilized
Lyophilized human plasma depleted for complement C4, supplied as a stable reconstitutable material for complement pathway research and assay controls.
Serum Amyloid A (SAA) deficient human plasma, lyophilized
Lyophilized human plasma prepared with reduced Serum Amyloid A levels for biomarker and immunoassay applications.
Services
Project-based sample testing, customized analysis and result reporting to support research studies and assay development.
Creation of pooled or single-donor lots tailored to demographic or analyte specifications, with pre-evaluation samples available on request.
Standing order management with scheduled shipments, cold-chain handling and rush shipment options to maintain laboratory supply continuity.
Project-based sample testing, customized analysis and result reporting to support research studies and assay development.
Creation of pooled or single-donor lots tailored to demographic or analyte specifications, with pre-evaluation samples available on request.
Standing order management with scheduled shipments, cold-chain handling and rush shipment options to maintain laboratory supply continuity.
Expertise Areas
- Biological sample sourcing and distribution
- Deficient plasma production and characterization (coagulation factors and biomarker-depleted materials)
- Immunoassay design and kit production (ELISA, chemiluminescent)
- Unit-level pathogen and microbial safety testing including NAT
Key Technologies
- ELISA
- Chemiluminescent immunoassay
- Immuno-depletion methods
- Chemical depletion processes preserving antigenicity
News & Updates
Blog post discussing the company's ELISA and CLIA kit offerings intended to support immunoassay research.
Product reference post about availability of human and animal-sourced tissue plasminogen activator (tPA).
Blog post highlighting overstock and availability of popular ELISA kits including coagulation factors and IgG assays.
Company states ISO 9001:2015 certification.
Company or facilities are described as FDA registered.
Animal collection facilities described as USDA approved.
Blog post discussing the company's ELISA and CLIA kit offerings intended to support immunoassay research.
Product reference post about availability of human and animal-sourced tissue plasminogen activator (tPA).
Blog post highlighting overstock and availability of popular ELISA kits including coagulation factors and IgG assays.
Company states ISO 9001:2015 certification.
Company or facilities are described as FDA registered.
Animal collection facilities described as USDA approved.